Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain
Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study compares buprenorphine/naloxone to opioid dose escalation among patients with
poorly controlled non-cancer pain on 30-100 mg daily morphine equivalent opioid dose.
Phase:
Phase 4
Details
Lead Sponsor:
VA Office of Research and Development
Treatments:
Analgesics, Opioid Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone